Results 61 to 70 of about 5,631 (161)
Chemistry Central Journal, 2017 Background A simple, rapid and accurate stability-indicating reverse phase high performance liquid chromatography (RP-HPLC) was developed and validated for the determination of brimonidine tartrate in brimonidine tartrate/poly(2-hydroxyethyl methacrylate)
Jianguo Sun, Xiuwen Zhang, Taomin Huang
doaj +1 more source
Emerging Medications in Facial Nerve Recovery: A Systematic Review and Meta‐Analysis
OTO Open, Volume 10, Issue 3, July-September 2026.Abstract Objective To systematically review the literature for medical therapies that promote facial nerve regeneration and recovery. Data Sources PubMed/Medline, Embase, and SCOPUS databases were searched for English‐language studies published from inception through May 2025.
Kimberly Chan +5 more
wiley +1 more source
Global scope of glaucoma clinical practice for optometrists
Optometry and Vision Science, Volume 103, Issue 7, July 2026.ABSTRACT Purpose The role of optometrists in glaucoma care is evolving rapidly in many parts of the world. This review aims to describe the current global scope of clinical practice for optometrists with respect to glaucoma, highlighting progress and identifying barriers to care across diverse regions.
Jonathan Denniss +9 more
wiley +1 more source
Preclinical Safety Profile of Brimonidine
, 1996 Brimonidine is a selective α2-adrenergic agonist developed for lowering intraocular pressure in glaucoma patients. Since brimonidine will be used in long-term theraphy, the safety of this drug is an important feature for its clinical success ...
O.V. Angelov +5 more
core +1 more source
, 2021 We evaluated glaucoma patients for the efficacy, safety and satisfaction associated with switching from brinzolamide 1% and brimonidine 0.1% to a fixed combination of brinzolamide 1% and brimonidine 0.1%. A total of 22 glaucoma patients were enrolled and
Kazuyuki Hirooka +8 more
core +1 more source
Macromolecular Bioscience, Volume 26, Issue 6, June 2026.ABSTRACT Dry eye syndrome (DES) happens as a result of inadequate tear secretion or excessive evaporation, which leads to ocular surface irritation and damage. A major therapeutic challenge is maintaining effective drug concentrations, as topical formulations are rapidly cleared by blinking and tear turnover.
Masoumeh Alsadat Hosseini +6 more
wiley +1 more source
, 2012 Purpose: To evaluate the efficacy of fixed combination brimonidine-timolol (FCBT) in comparison with brimonidine tartrate 0.2% and control for the treatment of intraocular pressure (IOP) spikes after neodymium:YAG (Nd:YAG) laser posterior capsulotomy ...
İşcan, Yalçın +4 more
core +1 more source
Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
Indian Journal of Ophthalmology, 2003 Purpose: To compare the short-term efficacy and safety of topical latanoprost and brimonidine in Indian eyes. Materials and Methods: Twenty-eight patients with ocular hypertension, primary open-angle, pseudoexfoliation or pigmentary glaucoma were ...
Thomas Ravi +5 more
doaj
Innovative Drug Delivery Systems for the Treatment of Glaucoma
MedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu +9 more
wiley +1 more source
The role of brimonidine tartrate gel in the treatment of rosacea
, 2015 J Mark Jackson,1 Melissa Knuckles,2 John Paul Minni,3 Sandra Marchese Johnson,4, Kevin Tate Belasco5 1Division of Dermatology, University of Louisville, Louisville, KY, USA; 2PSC, Dermatology, Corbin, KY, USA; 3Waters Edge Dermatology, Stuart, FL, USA ...
Jackson JM +4 more
core